Latest Health News

Page 16 of 235
Powerhouse Ventures holds $6.14 million in liquid assets and advances new technology fund launch despite challenging market conditions.
Claire Turing
Claire Turing
30 Apr 2026
Celsius Resources appoints Bardin Davis as MD to lead financing efforts for the MCB Copper-Gold Project, extends Final Investment Decision timeline to late 2026, and navigates a complex ownership dispute in the Philippines while raising A$9.3 million.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Dubber Corporation reported a historic positive underlying operating cashflow run-rate in Q3 FY26, driven by a USD 3.06 million initial payment from a Tier 1 North American communications service provider and ongoing cost reductions. Recurring revenue dipped 6% quarter-on-quarter due to portfolio optimisation and foreign exchange impacts.
Sophie Babbage
Sophie Babbage
30 Apr 2026
EMC Gold is pushing forward with a drilling campaign at its Salave Gold Project while navigating a procedural setback from the High Court of Asturias. The company also surrendered its Ivan Well tenement in WA and maintains a solid cash position of CAD$4.6 million.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Anatara Lifesciences delivered ambiguous mechanism of action results for its Anti-Obesity Project while reporting statistically significant weight management effects from compound AOC. The company plans a limited Phase 1 study but may delay it amid ongoing strategic discussions, with cash reserves tightening to $0.7 million.
Ada Torres
Ada Torres
29 Apr 2026
Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.
Ada Torres
Ada Torres
29 Apr 2026
Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.
Ada Torres
Ada Torres
29 Apr 2026
Culpeo Minerals has restructured its Lana Corina earn-in deal to slash near-term cash outlays and plans a fully funded 4,000m diamond drilling campaign at Vista Montana in Q2 2026, while advancing its Fortuna copper project and streamlining its shareholder base.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.
Ada Torres
Ada Torres
29 Apr 2026
Emyria Limited is extending its Empax mental health clinic network into New South Wales through a new partnership with Matilda Nepean Private Hospital, increasing treatment capacity and national reach ahead of a planned Q3 2026 launch.
Ada Torres
Ada Torres
29 Apr 2026
Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.
Ada Torres
Ada Torres
29 Apr 2026
Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.
Ada Torres
Ada Torres
29 Apr 2026